NCT00283660

Brief Summary

This study will determine whether supplements of the mineral zinc will improve mental health and school performance among schoolchildren in Guatemala.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Jan 2006

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

January 26, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 30, 2006

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2006

Completed
Last Updated

November 17, 2015

Status Verified

November 1, 2015

Enrollment Period

9 months

First QC Date

January 26, 2006

Last Update Submit

November 16, 2015

Conditions

Keywords

ZincDietary SupplementsNutritional SupplementsChildMental HealthSchoolGuatemala

Outcome Measures

Primary Outcomes (1)

  • Symptoms of depression

    Baseline and post supplementation

Secondary Outcomes (4)

  • Symptoms of anxiety

    Baseline and post supplementation

  • attention problems and school performance

    Baseline and post supplementation

  • activity levels

    Baseline and post supplementation

  • zinc levels

    Baseline and post supplementation

Study Arms (2)

Active

EXPERIMENTAL

Dietary Supplement: 10 mg zinc oxide

Dietary Supplement: 10 mg zinc oxide

Placebo

PLACEBO COMPARATOR

Placebo (double blinded)

Other: Placebo

Interventions

10 mg zinc oxideDIETARY_SUPPLEMENT

10 mg zinc oxide

Active
PlaceboOTHER

Placebo pill taken five days a week for six months.

Placebo

Eligibility Criteria

Age7 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Attend a public school in specific Guatemalan community and has thorough and up-to-date school records
  • Currently in 2nd to 6th grade
  • Parent or guardian willing to provide informed consent

You may not qualify if:

  • Any illness that may affect participants' zinc levels
  • Any chronic illness
  • History of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Nutrición de Centro América y Panamá - INCAP

Guatemala City, 01011, Guatemala

Location

Related Publications (2)

  • DiGirolamo AM, Ramirez-Zea M, Wang M, Flores-Ayala R, Martorell R, Neufeld LM, Ramakrishnan U, Sellen D, Black MM, Stein AD. Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am J Clin Nutr. 2010 Nov;92(5):1241-50. doi: 10.3945/ajcn.2010.29686. Epub 2010 Sep 29.

  • Bui VQ, Stein AD, DiGirolamo AM, Ramakrishnan U, Flores-Ayala RC, Ramirez-Zea M, Grant FK, Villalpando S, Martorell R. Associations between serum C-reactive protein and serum zinc, ferritin, and copper in Guatemalan school children. Biol Trace Elem Res. 2012 Aug;148(2):154-60. doi: 10.1007/s12011-012-9358-0. Epub 2012 Feb 22.

MeSH Terms

Conditions

DepressionAnxiety DisordersPsychological Well-Being

Interventions

Zinc Oxide

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersPersonal Satisfaction

Intervention Hierarchy (Ancestors)

OxidesOxygen CompoundsInorganic ChemicalsZinc Compounds

Study Officials

  • Aryeh D Stein, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Global Health

Study Record Dates

First Submitted

January 26, 2006

First Posted

January 30, 2006

Study Start

January 1, 2006

Primary Completion

October 1, 2006

Study Completion

October 1, 2006

Last Updated

November 17, 2015

Record last verified: 2015-11

Locations